News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hemispherx Biopharma (HEB) Enters Major Contract With Lovelace Respiratory Research Institute


11/18/2008 11:17:50 AM

PHILADELPHIA, Nov. 18, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB - News) announced it has entered a contract, valued at more than $1 Million, with Lovelace Respiratory Research Institute (LRRI), Albuquerque, N.M. LRRI is the nation's largest independent, not-for-profit organization conducting basic and applied research on the causes and treatment of respiratory illness and disease. LRRI research includes preclinical studies of new pharmaceuticals including Ampligen(r), an experimental therapeutic.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES